454 studies found for:    "Uveal diseases"
Show Display Options
Rank Status Study
1 Unknown  Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
2 Unknown  Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty
Condition: Corneal Edema Secondary to Corneal Endothelial Dystrophy
Intervention: Procedure: DSEAK
3 Completed
Has Results
Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment
Condition: Uveitis
Intervention: Drug: 0.59 mg Fluocinolone Acetonide implant
4 Completed Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Condition: Anterior Uveitis
Intervention: Drug: Difluprednate Ophthalmic Emulsion
5 Terminated A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis
Condition: Anterior Uveitis
Intervention: Drug: Dexamethasone
6 Recruiting Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation
Conditions: Inflammation;   Pain;   Cataract
Interventions: Drug: XG-102;   Drug: Placebo
7 Withdrawn A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
Conditions: Muckle Wells Syndrome;   Autoinflammatory;   Behcet's Disease
Intervention: Drug: XOMA 052
8 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
9 Active, not recruiting A Long-Term Safety Study of OZURDEX® in Clinical Practice
Conditions: Retinal Vein Occlusion;   Macular Edema;   Uveitis, Posterior
Intervention: Drug: dexamethasone 700 μg intravitreal implant
10 Enrolling by invitation Clinical Outcome in Uveitis
Condition: Uveitis
Intervention:
11 Completed Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis
Condition: Anterior Uveitis
Interventions: Drug: 40 mg/mL Dexamethasone phosphate ophthalmic solution;   Drug: Prednisolone Acetate (1%) Eyedrops;   Drug: 100 mM sodium citrate buffer solution;   Drug: Placebo Eyedrops
12 Recruiting Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
Conditions: Age Related Macular Degeneration;   Choroidal Neovascularization;   Central Serous Chorioretinopathy
Intervention:
13 Completed Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Conditions: Choroiditis;   Iridocyclitis;   Iritis;   Retinal Disease
Intervention:
14 Completed Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
Conditions: Age Related Macular Degeneration;   Choroidal Neovascularization;   Macular Edema
Interventions: Drug: Bevacizumab and verteporfin photodynamic therapy;   Drug: Bevacizumab and visudyne photodynamic therapy
15 Completed Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)
Conditions: Maculopathy, Age-Related;   Choroidal Neovascularization
Intervention:
16 Terminated Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis
Condition: Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
17 Recruiting Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Conditions: Age-Related Macular Degeneration;   Neovascularization, Choroidal
Interventions: Drug: Intravitreal dexamethasone and intravitreal ranibizumab;   Drug: Intravitreal ranibizumab
18 Not yet recruiting Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma
Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Iris Melanoma;   Stage I Intraocular Melanoma;   Stage IIA Intraocular Melanoma;   Stage IIB Intraocular Melanoma;   Stage IIIA Intraocular Melanoma;   Stage IIIB Intraocular Melanoma;   Stage IIIC Intraocular Melanoma
Interventions: Drug: Sunitinib;   Drug: Valproic Acid
19 Completed Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)
Condition: Age-Related Macular Degeneration
Intervention: Drug: PF-04523655
20 Completed Influencing Factors in Uveitis
Condition: Uveitis
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years